Investors in Edtech

OXO Group is a leading investment firm of the tech sector in the European region. It includes a network of business angels as well as various financial and strategic investors as equity partners. Our investment policy targets the funding, partial or full buyout of early stage tech ventures, accelerate their growth and market expansion and prepare them for subsequent funding rounds and exits.

Sofia Angels Ventures is a EUR 13 million co-investment venture capital fund backed by the European Investment Fund to co-invest on deal-by-deal basis alongside private co-investors (angels, family offices, funds and other private institutions). Focus on tech startups at the early stage of development. Ticket size of EUR 200k – EUR 500k for first investment and up-to EUR 1.0m for follow-on investments. The management team consists of professionals with considerable financial, entrepreneurial and operating experience, who themselves are angel investors. The management team has invested its own capital in the fund. Strong network of angel investors creates a unique advantage in deal sourcing.

VC fund focused on pre-seed and seed investments in Slovakia. We seek and actively connect ideas, people and a capital for the exponential growth of a company. We support ideas or companies at the beginning of their journey. We are not just a passive investor, we also have experience, skills and energy to actively help our companies achieve mutual success.

The first NHS-founded and backed venture fund for digital health and MedTech. Accelerating the future of healthcare in the UK and beyond.

Early-stage Fintech, DeepTech, and x-Tech investment across the UK, Europe, MNA, and APAC regions. We’re a UK based fund with a genuine curiosity for new challenges that have potential to expand to other continents, having backed founders from diverse backgrounds. Good ideas know no borders. And neither do our investments.

Brussels-based tech accelerator program. 3 months of acceleration for tech startups in AI, dual-use technology and cybersecurity. MedTech welcome starting next cohort. Our portfolio: https://seven.camp/portfolio

Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. Gilde Healthcare is headquartered in Utrecht (the Netherlands) with local offices in Frankfurt (Germany) and Boston (USA). Gilde Healthcare differentiates itself through its deep sector knowledge in healthcare, which has been acquired during the past decades. The investment team consisting of industry experts, ex-consultants and investors provides hands-on support to its managers in designing the growth strategy and by contributing domain expertise. Gilde Healthcare believes optimal value creation in healthcare is associated with better care at lower cost.

Scientipole Ile-de-France Capital is a French venture capital firm specialized in funding seed stage companies. Scientipôle Capital invests in the innovative tech-based startups, at early stage. Team keeps a close relationship during the entire investment period to help entrepreneurs to succeed in all areas of management Scientipôle Capital is focused on innovative technologies developed in the Paris-Saclay area: • Solutions for the industry 4.0 : digital technologies, industrial technologies • Green tech applications to support energy and ecological transitions - smart grid, smart city • Health / medtech (except drugs) ...

Netherlands-based deeptech and life sciences investor.

Birk Venture is a company based in Oslo, Norway, dedicated to transforming unique innovations and technologies into successful businesses in the healthcare sector. They focus on leveraging cutting-edge technologies in life science to meet the increasin.

Myelin VC is Investing in companies that accelerate collective intelligence. They collaborate with visionary outliers to pioneer the unimaginable, investing in founders whose ideas shape a future they envision living in. Their investment strategy spans across industries, from seed funding to Series A, supporting innovative ventures poised to disrupt and redefine their respective fields.

Columbus is a Spanish investment management company that focuses on generating high returns through the Columbus Innvierte Life Science fund. This fund targets seed-stage investments in established private companies within the healthcare and life sciences sectors. The company boasts a robust investment team with international experience and a proven track record in identifying innovative excellence originating from Spanish academic institutions. COLUMBUS VENTURE PARTNERS, SGEIC, SA leverages its expertise in company building and financing to accelerate commercialization for its portfolio companies. Additionally, it facilitates rapid access to the vibrant UK and Boston/Cambridge biotech/pharma venture capital R&D ecosystem.